Precision Oncology Market is expected to increase at a compound annual growth rate (CAGR) of 13.8% from 2025 to 2035

 

The market for precision oncology market was estimated to be worth USD 103.7 billion in 2024, and a compound annual growth rate of 13.8% is anticipated over the course of the projection period. The main factors driving the market are the growing impact of technology, the growing need to reduce the adverse effects of cancer treatments, and the avoidance of particular drug resistance. The market is expanding due to growing demand for early detection of breast cancer, the expansion of the biotechnology industry, and rising healthcare costs worldwide.

Innovation and the creation of new treatments are accelerated by rising governmental and private sector investment in research and development. The market is expanding due to favorable government financing and initiatives.

 

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/precision-oncology-market

 

Growth Drivers

The market is expanding due to a number of factors, including favorable government programs and funding, growing awareness of precision medicine, and technological advancements. More accurate detection of genetic alterations and biomarkers is made possible by advances in cancer genomics and the development of technologies such as next-generation sequencing. Transition to personalized medicine, which improves the effectiveness of cancer therapy and minimizes side effects by customizing medicines to each patient's unique genetic profile.

The market is greatly boosted by favorable regulatory regulations and expedited approvals for novel treatments and diagnostics. The market is expanding due in large part to the rising incidence of uterine fibrosis, breast cancer, and cancer worldwide. Another important aspect of the precision oncology industry is the growing need for customized medications.

Segmentation

Type

·         Breast Cancer

·         Prostate Cancer

·         Stomach Cancer

·         Liver Cancer

·         Mouth Cancer

·         Skin Cancer

·         Others

By Products Type

·         Therapeutics

·         Diagnostics

By End-User

·         Hospitals

·         Diagnostic Centers

·         Research and Academic Institutes

·         Others

Regional Outlook

·         Asia Pacific

·         North America

·         Latin America

·         Europe

·         Middle East and Africa

 

Key Players

·         Thermo Fisher Scientific Inc.

·         Novartis AG

·         Pfizer Inc.

·         Agendria Inc.

·         Rain Therapeutics Inc.

·         Strata Oncology, Inc.

·         F.Hoffman La Roche Ltd.

·         Qiagen N.V.

·         Invitae Corporation

·         Erasca Inc.

·         Other Players

 

For More Information about this Report @ https://www.xresearch.biz/shop/precision-oncology-market

 

About Us: -  

xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

                                   

Contact:                                           
Company Name: 
xResearch
Contact Person:  James Lin
Email: 
sales@xresearch.biz
Phone: +1 718-619-8140

Websites: https://www.xresearch.biz/


Comments

Popular posts from this blog

Microalgae Fertilizers Market is expected to increase at a compound annual growth rate (CAGR) of 12.1% from 2025 to 2035

Food Encapsulation Market is predicted to expand at a compounded annual growth rate (CAGR) of 6.8% during the forecast period

Food Thermometer Market is expected to increase at a compound annual growth rate (CAGR) of 15.3% from 2025 to 2035